Phase II Study Of ZD1839 (NSC 715055) In Newly Diagnosed Patients With Glioblastoma (Grade 4 Astrocytoma)
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2013
At a glance
- Drugs Gefitinib (Primary)
- Indications Glioblastoma
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 28 Oct 2008 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.